SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-16-003486
Filing Date
2016-06-21
Accepted
2016-06-21 16:43:28
Documents
2
Effectiveness Date
2016-06-21

Document Format Files

Seq Description Document Type Size
1 e615164_f6pos-neurovive.htm F-6 POS 85035
2 e615164_ex99-e.htm EX-99.(E) 19146
  Complete submission text file 0001193805-16-003486.txt   105627
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS

Mailing Address C/O PATTERSON BELKNAP C/O H. RASPE 1133 AVENUE OF THE AMERICAS NEW YORK NY 10036
Business Address MEDICON VILLAGE, SCHEELEVAGEN 2 LUND V7 00001 212-336-2301
NeuroVive Pharmaceuticals AB/ADR (Subject) CIK: 0001647420 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-205550 | Film No.: 161724815